HC Wainwright Begins Coverage on Avadel Pharmaceuticals (NASDAQ:AVDL)

HC Wainwright assumed coverage on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) in a report published on Friday morning, Marketbeat.com reports. The firm issued a buy rating and a $22.00 target price on the stock. Separately, Needham & Company LLC restated a “buy” rating and set a $19.00 target price on shares of Avadel […]

Leave a Reply

Your email address will not be published.

Previous post UK’s Bitcoin sell-off risks becoming another billion-pound blunder, warns deVere boss
Next post First Financial Bankshares (NASDAQ:FFIN) Price Target Raised to $38.00